NCT07327255: Pharmacokinetic Study to Evaluate Safety and Tolerability of EG-101 in Healthy Female Volunteers as a Safety Lead-In for Dosing in Pregnant Women With Severe Pre-eclampsia

Sponsor: Evergreen Therapeutics, Inc.. Phase: PHASE1. Conditions: Pre-eclampsia